Open Access Highly Accessed Study protocol

Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer

Marcia S Brose*, Christopher M Nutting, Steven I Sherman, Young K Shong, Johannes WA Smit, Gerhard Reike, John Chung, Joachim Kalmus, Christian Kappeler and Martin Schlumberger*

BMC Cancer 2011, 11:349 doi:10.1186/1471-2407-11-349

Accesses  

  • Last 30 days: 347 accesses
  • Last 365 days: 2394 accesses
  • All time: 4287 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations